Sionna Therapeutics Stock (NASDAQ:SION)

Ownership Financials Chart

Previous Close

$19.14

52W Range

$7.25 - $25.19

50D Avg

$16.50

200D Avg

$15.11

Market Cap

$842.78M

Avg Vol (3M)

$185.68K

Beta

3.39

Div Yield

-

SION Company Profile

Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

41

IPO Date

Feb 07, 2025

Website

SION Performance

SION Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	-	-	-
Operating Income	$-70.56M	$-50.33M	$-41.37M
Net Income	$-61.69M	$-47.26M	$-40.24M
EBITDA	$-69.89M	$-49.75M	$-41.25M
Basic EPS	$-1.45	$-1.70	$-2.32
Diluted EPS	$-15.99	$-1.70	$-2.32

Fiscal year ends in Dec 24 | Currency in USD